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Abstract
Introduction Current cell therapy for cartilage regeneration
requires invasive procedures, periosteal coverage and scaffold
use. We have developed a novel transplantation method with
synovial mesenchymal stem cells (MSCs) to adhere to the
cartilage defect.
Methods For ex vivo analysis in rabbits, the cartilage defect was
faced upward, filled with synovial MSC suspension, and held
stationary for 2.5 to 15 minutes. The number of attached cells
was examined. For in vivo analysis in rabbits, an autologous
synovial MSC suspension was placed on the cartilage defect,
and the position was maintained for 10 minutes to adhere the
cells to the defect. For the control, either the same cell
suspension was injected intra-articularly or the defects were left
empty. The three groups were compared macroscopically and
histologically. For ex vivo analysis in humans, in addition to the
similar experiment in rabbits, the expression and effects of
neutralizing antibodies for adhesion molecules were examined.
Results  Ex vivo analysis in rabbits demonstrated that the
number of attached cells increased in a time-dependent manner,
and more than 60% of cells attached within 10 minutes. The in
vivo study showed that a large number of transplanted synovial
MSCs attached to the defect at 1 day, and the cartilage defect
improved at 24 weeks. The histological score was consistently
better than the scores of the two control groups (same cell
suspension injected intra-articularly or defects left empty) at 4,
12, and 24 weeks. Ex vivo analysis in humans provided similar
results to those in rabbits. Intercellular adhesion molecule 1-
positive cells increased between 1 minute and 10 minutes, and
neutralizing antibodies for intercellular adhesion molecule 1,
vascular cell adhesion molecule 1 and activated leukocyte-cell
adhesion molecule inhibited the attachment.
Conclusion Placing MSC suspension on the cartilage defect for
10 minutes resulted in adherence of >60% of synovial MSCs to
the defect, and promoted cartilage regeneration. This adherent
method makes it possible to adhere MSCs with low invasion,
without periosteal coverage, and without a scaffold.
Introduction
Various methods have been reported for the treatment of artic-
ular cartilage injury. Marrow stimulation techniques [1,2] are
the most prevalent, but defects are often filled with fibrous car-
tilage and the repaired cartilage later degenerates [3]. Autolo-
gous osteochondral transplantation [4] and chondrocyte
transplantation [5] can regenerate hyaline cartilage; however,
the invasiveness of the procedures is of concern [6,7], thereby
limiting such applications for the repair of large defects.
Mesenchymal stem cells (MSCs) are an attractive cell source
for cartilage regenerative medicine because they can be har-
vested in a minimally invasive manner, are easily isolated and
expanded, and have multipotentiality that includes chondro-
genesis [8-10]. In addition, synovial MSCs are especially
promising due to their high proliferative capacity and chondro-
genic potential [11-16].
BSA = bovine serum albumin; DiI = 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; FBS = fetal bovine serum; GFP = green flu-
orescent protein; ICAM-1 = intercellular adhesion molecule 1; MEM, modified Eagle's medium; MSC = mesenchymal stem cell; PBS = phosphate-
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Treatment with chondrocytes and MSCs requires the trans-
plantation of a cell and scaffold composite with a periosteum
covering, and is presently a common repair method [17,18].
The method is extremely invasive, however, with a long incision
to the skin and capsule to harvest the periosteum, transplanta-
tion of the cell/gel composite, and fixation with suturing to the
neighboring cartilage. With periosteal coverage, hypertrophy
and ossification are of concern [17]. The most popular scaf-
fold is currently composed of collagen gel, which is produced
by type I collagen derived from animal skins, thereby introduc-
ing the risk of disease transmission and immune reaction [19].
We developed a novel transplantation procedure with synovial
MSCs for cartilage regeneration. The degree of surgical inva-
sion is as minimal as the marrow stimulation techniques, since
our procedure can also be performed arthroscopically. Scaf-
folds are not necessary, thereby increasing the safety and eco-
nomic feasibility. Our study will advance and extend the clinical
application of MSC-based cell therapy for cartilage injury.
Materials and methods
Rabbits
Skeletally mature Japanese White Rabbits weighing approxi-
mately 3.2 kg (ranging from 2.8 to 3.6 kg) were used in the
experiments. Animal care was in accordance with the guide-
lines of the animal committee of Tokyo Medical and Dental Uni-
versity. The operation was performed under anesthesia
induced by intramuscular injection of 25 mg/kg ketamine
hydrochloride and intravenous injection of 45 mg/kg sodium
pentobarbital.
Isolation and culture of synovial mesenchymal stem cells 
in rabbits
Synovium with the subsynovial tissue was harvested from the
left knee of the rabbits under anesthesia. The synovium was
digested in a 3 mg/ml collagenase D solution (Roche Diagnos-
tics, Mannheim, Germany) in αMEM (Invitrogen Corp.,
Carlsbad, CA, USA) at 37°C. After 3 hours, digested cells
were filtered through a 70-μm nylon filter (Becton Dickinson,
Franklin Lakes, NJ, USA), and the remaining tissues were dis-
carded. The digested cells were plated at 5 × 104 cells/cm2 in
150 cm2 culture dishes (Nalge Nunc International, Rochester,
NY, USA) in complete culture medium, αMEM containing 10%
FBS (lot selected for rapid growth of bone marrow derived
MSCs, 100 units/ml penicillin, 100 μg/ml streptomycin, and
250 ng/ml amphotericin B; Invitrogen Corp.), and were incu-
bated at 37°C with 5% humidified CO2. After 3 to 4 days, the
medium was changed to remove nonadherent cells, and the
adherent cells were cultured for 7 days as passage 0 without
refeeding. The cells were then trypsinized, harvested and
resuspended to be used for transplantation. We already
reported that these cells had characteristics of MSCs [20-22].
The cells that were transplanted in animals to be sacrificed at
day 1 were labeled for cell tracking by the fluorescent
lipophilic tracer 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocar-
bocyanine perchlorate (DiI) (Molecular Probes, Eugene, OR,
USA). For labeling, the cells were resuspended at 1 × 106
cells/ml in αMEM, and DiI was added at 5 μl/ml in αMEM. After
incubation for 20 minutes at 37°C with 5% humidified CO2,
the cells were centrifuged at 450 × g for 5 min and washed
twice with PBS [20,23], and the cells were then resuspended
in PBS for the transplantation.
Ex vivo sequential analysis of the number of attached 
cells in rabbits
Full-thickness osteochondral defects (5 mm × 5 mm wide, 3
mm deep) were created in the trochlear groove of the femurs
of adult rabbits. The distal end of the femurs were then
removed, and were precultured in serum-free Dulbecco's
MEM (Invitrogen) supplemented with 100 units/ml penicillin
(Invitrogen), 100 μg/ml streptomycin (Invitrogen), and 250 ng/
ml amphotericin B (Invitrogen) for 24 hours. To determine the
length of time needed for cell attachment to the defect, the
cartilage defect of the femoral condyle was faced upward.
Passage 0 autologous synovial MSCs, precultured for 7 days,
were used for the transplantation.
The defect was filled with DiI-labeled synovial MSC suspen-
sion, which consisted of 107 cells in 100 μl PBS, and was left
stationary for 2.5, 5, 7.5, 10, and 15 minutes. The femurs were
then turned with the defect side down for 10 minutes. This
allowed the nonadhered cells in the defect to discard the
defect in the culture medium (Figure 1a). The nonadhered
cells in the medium were collected, as were the nonadhered
cells attached to the dishes after trypsinization. The total
Figure 1
Ex vivo sequential analysis of cell attachment to rabbit cartilage defects  by local adherent technique Ex vivo sequential analysis of cell attachment to rabbit cartilage defects 
by local adherent technique. (a) Scheme for the method: image a, carti-
lage defect of the femoral condyle was faced upward and the defect 
was filled with 106 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocya-
nine perchlorate-labeled rabbit synovial mesenchymal stem cells in 100 
μl PBS; image b, defect was held stationary for 2.5, 5, 7.5, 10, and 15 
minutes; image c, femur was turned with the defect side down for 10 
minutes so that nonadhered cells in the defect fell in the culture 
medium. The nonattached cell number was then determined, and the 
attached cell number was extrapolated. (b) Cell number attached to the 
cartilage defects by the local adherent technique. Data expressed as 
the mean ± standard deviation (n = 3).Available online http://arthritis-research.com/content/10/4/R84
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number of nonadhered cells positive for DiI was counted.
Finally, the adhered cell number attached to the cartilage
defects was calculated by subtracting from 10 × 106 cells.
In vivo transplantation
Thirty-six rabbits were used for the in vivo transplantation
study. Autologous synovial MSC transplantation was per-
formed 7 days after the harvest. Under anesthesia, the right
knee joint was approached through a medial parapatellar inci-
sion, and the patella was dislocated laterally. Full-thickness
osteochondral defects (5 mm × 5 mm wide, 3 mm deep),
whose size were critical for rabbit knees [24], were created in
the trochlear groove of the femur.
The animals were divided into three groups for transplantation.
For the control group, the cartilage defect was left empty. For
the intra-articular group, 107 DiI-labeled autologous synovial
MSCs in 100 μl PBS were injected into the knee joint after the
capsule was closed. For the local adherent group, the defect
was filled with the cell suspension of 107DiI-labeled autolo-
gous synovial MSCs in 100 μl PBS and held stationary for 10
minutes with the defect upward. In no groups were the defects
patched, and a periosteum or artificial membrane was not
used. All rabbits were returned to their cages after the
operation and were allowed to move freely. Animals were sac-
rificed with an overdose of sodium pentobarbital at 1 day and
4, 12, and 24 weeks after the operation (n = 3 at each time
point).
Macroscopic examination
The cartilage defects were examined macroscopically for
color, integrity and smoothness. Osteoarthritic changes and
synovitis of the knee were also investigated. Macroscopic pic-
tures of the femoral condyles were taken for evaluation using
MPS-7 (Sugiura Laboratory Inc., Tokyo, Japan), a dedicated
medical photography platform. Digital images were taken
using a Nikon Coolpix 4500 digital camera (Nikon, Tokyo,
Japan).
Histological examination and fluorescent microscopic 
examination
The dissected distal femurs were immediately fixed in a 4%
paraformaldehyde solution. The specimens were decalcified in
4% ethylenediamine tetraacetic acid solution, dehydrated with
a gradient ethanol series, and embedded in paraffin blocks.
Sagittal sections 5 μm thick were obtained from the center of
each defect and were stained with toluidine blue. Sections
dedicated for fluorescent microscopic visualization of DiI-
labeled cells were not stained with toluidine blue, and nuclei
were counterstained by 4',6-diamidino-2-phenylindole
dihydrochloride.
Histological score
Histological sections of the repaired tissue were analyzed
using a grading system consisting of five categories (cell mor-
phology, matrix staining, surface regularity, cartilage thickness,
and integration of donor with host), which were modified from
the repaired cartilage score described by Wakitani and col-
leagues [25], so that overly thick regenerated cartilage could
not be overestimated (Table 1). The scoring was performed in
a blinded manner by two observers, and there was no signifi-
cant interobserver difference.
Ex vivo sequential analysis of the number of attached 
cells in humans
The study was approved by our Institutional Review Board,
and informed consent was obtained from all study subjects.
Human synovium and cartilage were harvested during total
Table 1
Histological scoring system for cartilage repair
Category Points
Cell morphology
Hyaline cartilage 4
Mostly hyaline cartilage 3
Mostly fibrocartilage 2
Mostly non-cartilage 1
Noncartilage only 0
Matrix-staining (metachromasia)
Normal (compared with host adjacent cartilage) 3
Slightly reduces 2
Markedly reduced 1
No metachromatic stain 0
Surface regularitya
Smooth (>3/4) 3
Moderate (1/2 to 3/4) 2
Irregular (1/4 to 1/2) 1
Severely irregular (<1/4) 0
Thickness of cartilageb
2/3 to 4/3 3
5/3 to 4/3 2
1/3 to 2/3 or >5/3 1
<1/3 0
Integration of donor with host adjacent cartilage
Both edges integrated 2
One edge integrated 1
Neither edge integrated 0
Total maximum 15
aTotal smooth area of the reparative cartilage compared with the 
entire area of the cartilage defect. bAverage thickness of the 
reparative cartilage compared with that of the surrounding cartilage.Arthritis Research & Therapy    Vol 10 No 4    Koga et al.
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knee arthroplasty with medial compartment osteoarthritis. Syn-
ovial tissue was minced into small pieces, digested in a colla-
genase solution, and then filtered. Nucleated cells were
cultured for 14 days. Passage 3 cells were used for further
analyses [15].
Osteochondral fragments at the lateral femoral condyle were
diced with a bone saw. The cartilage defects 2.5 mm in diam-
eter were created and filled with 800 × 103 DiI-labeled human
synovial MSCs in 8 μl PBS. After 5, 10, 20, and 30 minutes,
the cartilage defects were turned down for 10 minutes. After
trypsinization, the DiI-positive cells in the dish were counted,
and number of the cell attached to the cartilage defects was
calculated by subtracting from 800 × 103 cells.
Immunohistochemistry
The sections of the human osteochondral fragments were
deparaffinized, washed in PBS, and pretreated with 0.4 mg/ml
proteinase K (DAKO, Carpinteria, CA, USA) in Tris–HCl buffer
for 15 minutes at room temperature. Endogenous peroxidases
were quenched using 3% hydrogen peroxide in methanol for
20 minutes at room temperature. The sections were rinsed
three times in PBS for 5 minutes and were briefly blocked with
5% normal horse or rabbit serum (Vector Laboratories, Burlin-
game, CA, USA) to avoid nonspecific binding of the antibody.
The sections were then incubated in mouse monoclonal anti-
human intercellular adhesion molecule 1 (ICAM-1) antibody
(1:50 dilution; SANBIO BV, Uden, Netherlands) or in goat
anti-human vascular adhesion molecule 1 (VCAM-1) antibody
(1:100 dilution; R&D Systems, Wiesbarden, Germany) at
room temperature for 1 hour. After rinsing in PBS, the tissues
were incubated with biotinylated horse anti-mouse or rabbit
anti-goat IgG secondary antibody (Vector Laboratories) for 30
minutes at room temperature. After incubation for another 30
minutes with Vectastain ABC reagent (Vector Laboratories),
the slides were counterstained with Mayer hematoxylin, dehy-
drated, and mounted in a xylol-soluble mount (Vitro-Club; Lan-
genbrinck, Emmendingen, Germany).
Neutralizing antibodies for adhesion molecules in 
human samples
Three million DiI-labeled human synovial MSCs were incu-
bated in 2 ml PBS including 1% BSA with 10 μg/ml neutraliz-
ing antibody for human ICAM-1, VCAM-1, activated leukocyte-
cell adhesion molecule, or mouse IgG1 isotype control anti-
body (R&D Systems) for 30 minutes at 37°C with 5% humidi-
fied CO2 [26]. After the supernatant was discarded, 800 ×
103 cells resuspended in 8 μl PBS were placed on the carti-
lage defect of osteocartilage fragment and held stationary for
10 minutes. The cartilage defects were then turned down for
10 minutes.
ICAM-1 expression in synovial mesenchymal stem cells 
after plating on slide grasses
Human synovial MSCs at 500 × 103 in 10 μl PBS were placed
on eight-well chamber glass slides (BD Bioscience) and
washed by PBS at 1 minute and 10 minutes, and were then
fixed with 99.5% acetone for 15 minutes. The glass slides
were stained with mouse monoclonal anti-human ICAM-1 anti-
body (1:10 dilution with PBS in 5% goat serum; R&D Sys-
tems) for 2 hours. After rinsing with PBS three times, the slides
were stained with goat anti-mouse IgG secondary antibody
labeled with Alexa fluor 568 (Invitrogen) for 1 hour. The nuclei
were stained with Hoechst 33342 (Invitrogen). The number of
ICAM-1-positive cells and nuclei was counted in three high-
power fields.
Statistical analysis
To assess differences, the Kruskal–Wallis test and the
Mann–Whitney U test were used. P < 0.05 was considered
significant.
Results
Ex vivo analysis of the number of cells attached to 
cartilage defects in rabbits
To clarify the minimum time for an adequate number of synovial
MSCs to attach to the cartilage defect by the local adherent
technique, we performed an ex vivo sequential analysis using
rabbit synovial MSCs and rabbit cartilage (Figure 1a). The
number of attached cells increased in a time-dependent man-
ner, and more than 60% of the cells attached in 10 minutes
(Figure 1b).
Macroscopic observation for the in vivo study
Osteochondral defects were created in rabbit knees. For the
control group, the cartilage defect was left empty. For the
intra-articular group, synovial MSCs were injected into the
knee joint after the capsule was closed. For the local adherent
group, the defect was filled with the synovial MSC suspension
and faced upward for 10 minutes according to the ex vivo
analyses.
At 1 day, the cartilage defects were overlaid with blood clots,
and there seemed to be no obvious differences among the
control, intra-articular, and local adherent groups macroscopi-
cally (data not shown).
At 4 weeks, the cartilage defect in the control group still
showed reddish tissue (Figure 2b, image a). In the intra-artic-
ular group, the defect was covered with whitish tissue in some
areas, but the reddish area remained in other areas (Figure 2b,
image b). In the local adherent group, the defect became whit-
ish and glossy in the entire area (Figure 2b, image c).
At 12 weeks, in the control and intra-articular groups, the red-
dish regions decreased in size but still remained locally (Figure
2b, images d and e). In the local adherent group, the borderAvailable online http://arthritis-research.com/content/10/4/R84
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between repaired tissue and neighboring cartilage appeared
less distinct (Figure 2b, image f).
At 24 weeks, the cartilage defect area in the control group
decreased but still remained (Figure 2b, image g). In the intra-
articular group, the defects were covered with whitish tissue
but the margins were still distinct (Figure 2b, image h). In the
local adherent group, the peripheral lesion of the defect
appeared to integrate into the surrounding native cartilage
(Figure 2b, image i).
In all three groups there were no obvious features of hydrar-
throsis or synovial proliferation. Mild spur formation was
observed on the edge of the trochlear groove of the femur in
some samples of the control group, but there were no osteoar-
thritic changes of the femorotibial joint in any groups.
Histological observation for in vivo study
At 1 day, the defect in the control group was filled with blood
clots (Figure 3a, images a and b). In the intra-articular group,
DiI-positive synovial MSCs were observed in the defect (Fig-
ure 3a, images c and d); the cells were very sparse when
examined at higher magnification, however, even in the
selected area where relatively dense DiI-positive cells were
observed in lower magnification (Figure 3a, images e and f). In
contrast, in the local adherent group, there were more DiI-pos-
itive synovial MSCs along with the osteochondral defect, with
the cellular layer 20 cells deep (Figure 3a, images g and h). DiI-
positive cells were denser in the local adherent group (Figure
3a, images I and j) than in the intra-articular group.
Figure 2
In vivo analysis of cartilage repair by synovial mesenchymal stem cell  transplantation in rabbits In vivo analysis of cartilage repair by synovial mesenchymal stem cell 
transplantation in rabbits. (a) Cell transplantation on a cartilage defect 
in a rabbit by the local adherent technique. The osteochondral defect 
was faced upward (upper panel), and the defect was filled with synovial 
mesenchymal stem cell (MSC) suspension (lower panel) and held sta-
tionary for 10 minutes for the cells to adhere. (b) Macroscopic observa-
tion of cartilage defects after cell transplantation. For the control group, 
the cartilage defect was left empty. For the intra-articular group, syno-
vial MSCs were injected into the knee joint after the capsule was 
closed. For the local adherent group, the defect was filled with the syn-
ovial MSC suspension and held still for 10 minutes. Femoral condyles 
4, 12 and 24 weeks post surgery are shown. The corners of the margin 
between repaired tissue and native cartilage are indicated as arrow-
heads in the local adherent group at 24 weeks.
Figure 3
Histological analyses Histological analyses. (a) Observation 1 day after cell transplantation. 
Sagittal sections stained with Toluidine blue (TB) and the serial sec-
tions under fluorescence for the 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-
indocarbocyanine perchlorate (DiI) label are shown. Higher 
magnifications of the framed areas are shown in images e, f, i, and j. 
The nuclei were counterstained by 4',6-diamidino-2-phenylindole dihy-
drochloride in images f and j. Bars (a to d, g, h) = 1 mm; bars (e, f, i, j) = 
100 μm. (b) Sagittal sections stained with TB. The distal side is shown 
on the right side of the image. Bars = 1 mm. (c) Histological score for 
the cartilage defect after cell transplantation. Histological findings were 
quantitated using the scoring system (Table 1), in which a full score 
was 15 and a higher score indicates cartilage repair. The scores of the 
local adherent group improved continuously through 24 weeks and 
were better than those of other groups at each point. Data expressed 
as the mean ± standard deviation (n = 3; P < 0.05 by Kruskal–Wallis 
test).Arthritis Research & Therapy    Vol 10 No 4    Koga et al.
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At 4 weeks, the defect in the control group was filled with
fibrous tissue and the cartilage matrix formation was poor
(Figure 3b, image a). In the intra-articular group, although more
cartilage matrix could be observed than in the control group,
the height of the repaired tissue was lower than that of the sur-
rounding cartilage (Figure 3b, image b). In the local adherent
group, the defect was filled with abundant cartilage matrix. In
addition in the local adherent group, remodeling of the carti-
lage into the underlying bone was observed in deep areas
(Figure 3b, image c).
At 12 weeks, in the control and intra-articular groups, the
defects were filled with fibrous tissues and were poorly healed
(Figure 3b, images d and e). In the local adherent group, the
cartilage matrix at the defect still remained, and the border
between regenerated cartilage and subchondral bone moved
upward. Integration between native cartilage and regenerated
tissue appeared to be improved (Figure 3b, image f).
At 24 weeks, in the control and intra-articular groups, the car-
tilage defects were still not healed (Figure 3b, images g and
h). In the local adherent group, the regenerated cartilage
matrix was well developed. The subchondral bone moved fur-
ther upward, and the thickness of the regenerated cartilage
was similar to that of the neighboring cartilage. The borders
between the native and regenerated tissue were well inte-
grated (Figure 3b, image i).
The histological scores of the local adherent group improved
continuously through 24 weeks and were always better than
those of the control group and the intra-articular group at each
point (Figure 3c).
Ex vivo analysis of human synovial mesenchymal stem 
cell attachment to human cartilage defect
The results described above were obtained using rabbit
MSCs. We investigated whether human MSC exhibited the
same capacity as rabbit cells to adhere to cartilage with the
same kinetics. The defects of cartilage obtained from humans
were faced upward, filled with 800 × 103 DiI-labeled human
synovial MSCs, and the position maintained for 5 to 30
minutes.
Macroscopically, the cartilage defect looked yellowish at time
0, slightly reddish at 5 minutes, and red at 10 minutes and
thereafter (Figure 4a). The cell number attached to the carti-
lage defect increased rapidly at 5 minutes, and then started to
rise slowly (Figure 4b). It should be noted that more than 60%
of the human synovial MSCs already adhered to the cartilage
defects at 10 minutes, indicating similarity between rabbits
and humans.
Adhesion molecules
It is expected that adhesion molecules are involved in cell
attachment. Ten minutes after filling human synovial MSCs in
Figure 4
Ex vivo analysis of human synovial mesenchymal stem cell attachment  to human cartilage defect Ex vivo analysis of human synovial mesenchymal stem cell attachment 
to human cartilage defect. The cartilage defect at 2.5 mm diameter was 
faced upward, filled with 800 × 103 1,1'-dioctadecyl-3,3,3',3'-tetrame-
thylindocarbocyanine perchlorate (DiI)-labeled human synovial mesen-
chymal stem cells (MSCs) in 8 μl PBS, and held stationary for 5, 10, 
20, and 30 minutes. (a) Macroscopic features of cartilage defects filled 
with DiI-labeled human synovial MSCs for the indicated time. Bar = 2.5 
mm. (b) Cell number attached to the cartilage defects. Data expressed 
as the mean ± standard deviation (n = 3). (c) Adhesion molecule 
expressions in cartilage defects filled with synovial MSC suspension for 
10 minutes. Bars = 50 μm. Ab, antibody; ICAM-1, intercellular adhe-
sion molecule 1; VCAM-1, vascular adhesion molecule 1. (d) Effects of 
neutralizing antibodies for adhesion molecules on attachment of human 
synovial MSCs on human cartilage defects. The cartilage defect was 
filled with DiI-labeled human synovial MSC suspension with control or 
neutralizing antibodies. After 10 minutes, the attached cell number was 
measured. Data expressed as the mean ± standard deviation (n = 3; P 
< 0.05 by Kruskal–Wallis test). ALCAM, activated leukocyte-cell adhe-
sion molecule.Available online http://arthritis-research.com/content/10/4/R84
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human cartilage defect, adhered cells expressed ICAM-1 and
VCAM-1 (Figure 4c). Neutralizing antibodies for ICAM-1,
VCAM-1, and activated leukocyte-cell adhesion molecule,
separately or together, inhibited attachment of human synovial
MSCs to human cartilage defects (Figure 4d). When human
synovial MSCs were plated on grass slides, ICAM-1-positive
cells significantly increased between 1 minute and 10 minutes
(Figure 5a,b).
Morphological event during a 10 minute period
We finally examined the morphological change of human syn-
ovial MSCs during a 10-minute period after plating on a cul-
ture dish. Most cells looked thick and round at 1 minute. They
became thinner, larger, and polygonal at 10 minutes (Figure
5c).
Discussion
For successful cartilage regeneration with MSCs, a sufficient
number of cells are required in the defect of the cartilage. The
number of MSCs decreased along with the period during
chondrogenesis in vitro [12,27] and in vivo [20] due to apop-
tosis of the MSCs [28]. Chondrogenic potential of MSCs
depends on the cell number in vitro [29]. We previously
reported that transplantation of synovial MSCs/gel compos-
ites with 5 × 107 cells/ml provided better results than trans-
plantation of composites with 106  cells/ml for the similar
cartilage defects in rabbits [21]. These findings indicate that
transplanted MSCs do not increase, and a higher number of
MSCs can provide better results for cartilage regeneration. In
the present study we chose a dose of 108 cells/ml MSC sus-
pension for the ex vivo and in vivo investigation. This concen-
tration is the maximum for preparing cell suspension.
We previously created the same full-thickness cartilage defect
in rabbits, and transplanted a synovial MSC/collagen gel com-
plex, which was covered with periosteum. The defect was
repaired successfully [20], and histological scores were simi-
lar using collagen gel and using the local adherence
technique.
We believe that the local adherent technique is much less
invasive and more attractive for clinical application.
Before we performed this research, we had speculated that
intra-articular injection of MSCs might result in better improve-
ment of the cartilage defect than it actually did. Practically,
most of the intra-articular injected cells adhered to synovial tis-
sue (data not shown), and only a small portion of the cells
adhered to the cartilage defect. Injection of more cells would
increase the number of cells that adhered to the defect; how-
ever, the injection of a large number of cells would also
increase the number of cells that adhered to the synovium,
thereby increasing the risk of adverse effects such as synovial
proliferation. The local adherent technique we describe here
Figure 5
Molecular and morphological events during a 10-minute period Molecular and morphological events during a 10-minute period. (a) 
Intercellular adhesion molecule 1 (ICAM-1) expression in human syno-
vial mesenchymal stem cells (MSCs) 1 minute and 10 minutes after 
plating on glass slides. ICAM-1-positive cells are shown as light shad-
ing, and nuclei as dark shading. Bars = 100 μm. (b) ICAM-1-positive 
cell rate. The number of ICAM-1-positive cells and nuclei were counted 
in three high-power fields. Data expressed as the mean ± standard 
deviation (*P < 0.05 by Mann–Whitney U test). (c) Morphological alter-
ations of human synovial MSCs between 1 minute and 10 minutes after 
plating on a culture dish. Bars = 50 μm.Arthritis Research & Therapy    Vol 10 No 4    Koga et al.
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made it possible to adhere the cells to the defect site more
effectively than an intra-articular injection technique.
In this research, human synovial MSCs attached to the carti-
lage defect 10 minutes after plating already expressed ICAM-
1 and VCAM-1, and neutralizing antibodies for ICAM-1,
VCAM-1, or activated leukocyte-cell adhesion molecule inhib-
ited the attachment. The ICAM-1-positive cell rate also
increased 10 minutes after plating on glass slides. Attachment
of synovial MSCs within 10 minutes was mediated by these
adhesion molecules. Their modification may have increased
the efficacy of cell attachment.
Our ex vivo studies demonstrated that more than 60% of syn-
ovial MSCs adhered to the cartilage defect after synovial MSC
suspension was placed on the cartilage defect for 10 minutes
both in humans and rabbits. The remaining nonadherent syno-
vial MSCs seemed to attach to synovial tissue in the knee joint.
When we injected 107 GFP-positive rat synovial MSCs into
the knee with meniscal defect in rats, GFP-positive cells were
observed in the meniscal defect and in the synovial tissues.
GFP mRNA expressions were also detected in the synovium,
but not in the brain, the lung, the liver, the kidney, and the
spleen [30]. Furthermore, our in vivo imaging system could not
be detected in any other organs expect the knee when
luciferase-positive synovial MSCs were injected into normal
rat knee (data not shown). These findings indicate that synovial
MSCs transplanted into the knee are not distributed to other
organs.
We previously compared the in vivo chondrogenic potential of
synovial MSCs, bone marrow MSCs, adipose MSCs, and
muscle MSCs by transplanting them into cartilage defects in
rabbits. Synovial MSCs and bone marrow MSCs had much
more chondrogenic potential than adipose MSCs and muscle
MSCs [21]. For clinical safety, autologous human serum
should be used instead of FBS. We recently reported that
autologous human serum predominated in increasing the pro-
liferation of human synovial MSCs rather than human bone
marrow MSCs [16]. These results indicate that synovial MSCs
and bone marrow MSCs are useful cell sources for cartilage
regeneration, but it is easier to prepare a sufficient number in
synovial MSCs than in bone marrow MSCs when autologous
serum is used.
In the original autologous chondrocyte transplantation tech-
nique, the cartilage defect was covered with the periosteum
and then chondrocyte suspension was injected into the defect
[5]. One poor aspect of the autologous chondrocyte trans-
plantation method was the leakage of the cell suspension;
however, the original autologous chondrocyte transplantation
method produced successful results. We speculate that
chondrocytes in suspension might adhere to the cartilage
defect soon after chondrocyte suspension is injected into the
defect.
For clinical application, we summarize the local adhesion tech-
nique as follows. When the operation for the cartilage injury is
performed (Figure 6a), the knee is positioned so that the car-
tilage defect is upward (Figure 6b). The synovial MSC suspen-
sion is then slowly dripped onto the cartilage defect and the
knee is held stationary for 10 minutes. The knee position is
then permitted to be changed and the synovial MSCs are
adhered to the cartilage defect (Figure 6c). The transplanted
synovial MSCs differentiate appropriately for the local micro-
environment, and the cartilage regenerates (Figure 6d).
Additionally, this procedure can be performed arthroscopi-
Figure 6
Application of low-invasive local adherent technique to transplant syno- vial mesenchymal stem cells into cartilage defect Application of low-invasive local adherent technique to transplant syno-
vial mesenchymal stem cells into cartilage defect. (a) For illustration, 
the cartilage defect is located on the condyles of the femur in the knee 
joint. (b) Knee is positioned so that the cartilage defect is faced 
upward. The synovial mesenchymal stem cell (MSC) suspension is then 
slowly dripped onto the cartilage defect, and the knee is held stationary 
for 10 minutes. (c) Knee position is permitted to be changed, and the 
synovial MSCs have adhered to the cartilage defect. (d) Transplanted 
synovial MSCs differentiate according to the microenvironment, and 
the cartilage regenerates.Available online http://arthritis-research.com/content/10/4/R84
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cally, without the need for additional scaffold, from the cell har-
vest to the transplantation. This protocol will advance and
extend the clinical application of MSC-based cell therapy for
cartilage injury.
Conclusion
We developed a novel implantation procedure with synovial
MSCs for cartilage regeneration. The local adherent technique
could achieve successful cartilage regeneration with low inva-
sion, without periosteal coverage, and without a scaffold. This
will advance and extend clinical application of MSC-based cell
therapy for cartilage injury.
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